[Treatment of primary hyperlipidemia with 5-methylpyrazinecarboxylic acid (acipimox)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D011719:Pyrazines; D014280:Triglycerides; D002784:Cholesterol; C027696:acipimox
Tratamento da hiperlipidemia primária com ácido 5-metil-pirazina -2-carboxílico (acipimox).